JSJason M. Souza

Jason M. Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jason M. Souza has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Surgical Care of the Traumatized Lower Extremity

    by Mark D. Mishu, Sami Ramadan, Jason M. Souza

    Learning Objectives: After studying this article, the participant should be able to: 1. Describe the principles of early and definitive management of lower extremity trauma and the importance of an evidence-based approach to these complex injuries. 2. List the benefits of a collaborative orthoplastic approach to decision-making and management in patients undergoing limb salvage. 3. Assess the need for formalized guidelines and treatment protocols to optimize the management of lower extremity trauma. Summary: Many open lower extremity fractures occur each year, and complications arising from suboptimal management impose substantial financial and functional burdens. An evidence-based approach emphasizing the timing and approach to soft-tissue reconstruction has been demonstrated to result in improved outcomes. A collaborative orthoplastic approach is critical to achieving this goal. The role of the reconstructive surgeon within this multidisciplinary team is central throughout the continuum of care, from initial hospital presentation to definitive soft-tissue coverage.

  • Open Access

    Bone Mineral Density After Transfemoral Amputation Osseointegration: A 2-Year Longitudinal Analysis

    by Benjamin K. Potter, Julio Rivera, Bradford D. Hendershot, Ashley B. Bozzay, Jason M. Souza, Jonathan A. Forsberg

    Background:Bone mineral density (BMD) loss is common after lower extremity amputation, but skeletal adaptation after transfemoral osseointegration remains poorly characterized. This study evaluated longitudinal changes in femoral neck BMD after transfemoral osseointegration and identified factors associated with BMD change. Methods:This single-center retrospective study included patients who underwent unilateral or bilateral transfemoral osseointegration and completed 2-year follow-up. Femoral neck BMD was assessed at baseline and at 3, 6, 12, and 24 months postoperatively. The primary outcome was change in femoral neck BMD from baseline to 24 months. Associations between BMD change and patient characteristics, gait-derived biomechanical loading measures, and patient-reported outcomes were evaluated using correlation analyses and multivariable linear regression. Results:A total of 37 patients were included (23 unilateral and 14 bilateral). BMD in the osseointegrated limb decreased during the first postoperative year, reached a nadir at 12 months, and recovered toward baseline by 24 months, while the contralateral (non-osseointegrated) limb remained stable. Changes in BMD were not associated with age, time since amputation, laterality, biomechanical loading measures, or patient-reported outcomes (all p > 0.05). Higher adjusted BMI was associated with greater decreases in BMD (β = –0.0078 per unit increase, p = 0.021), with consistent findings across correlation and multivariable analyses. Conclusion:BMD declines during the first postoperative year after transfemoral osseointegration but recovers toward baseline by 2 years, with no evidence of sustained bone loss. Changes in BMD are not associated with self-reported functional or gait-derived biomechanical measures, suggesting that skeletal adaptation occurs independently of functional recovery in the early postoperative period. Higher BMI may be associated with less favorable skeletal adaptation.

  • Open Access

    Patient-Specific Virtual Surgical Planning and In-House CAD-/CAM-Guided Vascularized Bone Flaps for Salvage Extremity Reconstruction: A Case Series

    by Jaideep Seth, Matthew D. Marquardt, Rachel Herster, Teri Snyder, David W. Nash, John Alexander, Angela C. Collins, Jason M. Souza, Humza S. Shaikh, Juan E. Santiago-Torres, et al.

    The surgical management of extremity bone defects, particularly post-traumatic nonunion wounds, remains a challenge. Vascularized bone flaps (VBFs), widely used for mandibular reconstruction in head and neck oncologic surgery, are less established in extremity reconstruction and are typically performed freehand, which has several limitations. In the past decade, virtual surgical planning (VSP) and computer-aided design and modeling (CAD-CAM) technology have enabled patient-specific 3D-printed models to guide reconstruction. While this technology has been used extensively in head and neck reconstructive surgery, its application to extremity reconstruction is less well-documented. This case series evaluates the feasibility, safety, and surgical utility of VSP and in-house CAD-CAM manufacture of 3D-printed models and cutting guides for post-traumatic non-healing extremity reconstructions using VBFs. Eight patients at a single tertiary academic center underwent VBF reconstruction guided by patient-specific models and cutting guides, with cases grouped into categories (humerus, femur, and tibia). The multi-disciplinary workflow supported preoperative visualization, osteotomy planning, and intraoperative execution. All vascularized flaps survived, and radiographic union was documented in patients with adequate follow-up. These findings suggest that integrating VSP and CAD-CAM into trauma-associated VBF extremity reconstruction is feasible and safe and may improve reconstructive accuracy and enhance multi-disciplinary team workflow, potentially contributing to improved clinical outcomes.

  • Osseointegration of the Upper Extremity

    by Sami Ramadan, Jason M. Souza

  • Do amputation characteristics predict outcomes measures and infections after osseointegration surgery?

    by Julio A. Rivera, Ashley B. Bozzay, Jason M. Souza, Benjamin K. Potter, Jonathan A. Forsberg

    Objective: To determine which patient characteristics are associated with patient-reported outcomes and infection outcomes after transfemoral osseointegration surgery. Methods: Design: Single-center retrospective study. Setting: Walter Reed National Military Medical Center, Bethesda, MD. Patient Selection Criteria: Patients who underwent unilateral or bilateral transfemoral osseointegration surgery and completed 2-year follow-up. Outcome Measures and Comparisons: Baseline patient characteristics (age at primary amputation, time living with limb loss, residual femur length, age at osseointegration surgery, and limb-loss–adjusted body mass index [BMI]) were evaluated as predictors of change in patient-reported outcomes from baseline to 2-year follow-up (Q-TFA domains, PROMIS domains, and patient-reported prosthesis use) and of infection outcomes (any infection and number of infections), using generalized linear models with AIC-guided backward elimination and adjustment for amputation laterality (unilateral vs bilateral). Results: There were 54 patients included (37 unilateral and 17 bilateral) who completed 2-year follow-up. The unilateral cohort had a mean age of 41.1 years (range, 24–72) and was predominantly male (33 males, 4 females), whereas the bilateral cohort had a mean age of 33.6 years (range, 26–41) and consisted entirely of male patients. Adjusted BMI best predicted changes in Q-TFA Global (R 2 = 0.06, F(1,48) = 3.8, p = 0.05) and Problem scores (R 2 = 0.07, F(1,48) = 4.7, p = 0.03), as well as PROMIS Pain Interference (R 2 = 0.25, F(1,50) = 17.8, p < 0.001) and Pain Behavior scores (R 2 = 0.26, F(1,50) = 18.7, p < 0.001) between baseline and 2-year follow-up. Adjusted BMI also best predicted changes in Q-TFA Prosthetic Use, PROMIS Physical Function, and prosthesis use time. Adjusted BMI was the strongest predictor of the number of infections. Conclusion: Among unilateral and bilateral transfemoral amputees undergoing osseointegration surgery with 2-year follow-up, lower adjusted BMI was associated with improved patient-reported outcomes and fewer infection events. Differences between unilateral and bilateral amputees suggest amputation laterality may modify postoperative outcomes. Level of Evidence: Therapeutic Level III

  • Open Access

    A conceptual framework for soft tissue management of transdermal bone-anchored implants in extremity prostheses

    by Matthew Wordsworth, Colin J. Harrington, Luke Juckett, Jason M. Souza, Global Collaborative Congress on Osseointegration (GCCO) Hsu Joseph R. Seymour Rachel B. Potter Benjamin K. Melton Danielle Fearing Bailey V. Gitajn Leah Hoellwarth Jason Rozbruch Robert Souza Jason Stanley Amber Stoneback Jason Wally Meghan K. Wenke Josh, Joseph R. Collaborators Hsu, Rachel B. Seymour, Benjamin K. Potter, Danielle Melton, Bailey V. Fearing, et al.

    Soft tissue complications are among the most common reasons for revision surgery following transdermal, bone-anchored osseointegration. While many orthopaedic surgeons are familiar and experienced with the use of intramedullary implants, the soft tissue management surrounding a percutaneous and permanent implant in continuity with the outside environment remains a challenging problem. With this in mind, we present our rationale and a framework for soft tissue considerations in preparation for bone-anchored osseointegration based on early experiences with most commercially available osseointegration systems.

  • Top Cited Papers

    What Functional Outcomes Can Be Expected With Osseointegrated Prostheses in Transfemoral Amputations?

    by Benjamin K. Potter, Julio A. Rivera, Ashley B. Anderson, Jason M. Souza, Jonathan A. Forsberg

    Background: Individuals who have undergone transfemoral amputation often have difficulty donning and utilizing a conventional socket prosthesis. Osseointegrated prostheses may alleviate certain issues, potentially resulting in better outcomes, but few prospective studies have either evaluated these outcomes or quantified the purported benefits. Questions/purposes: (1) Did patient-reported outcome measures improve between baseline and 2-year follow-up among those who underwent osseointegration surgery after transfemoral amputation? (2) What was the frequency and severity of early complications related to the osseointegration procedures? (3) What was the minimum clinically important difference (MCID) in a global patient-reported outcome measure in this patient population? Methods: Between October 2017 and October 2023, we recruited 41 participants to undergo transfemoral osseointegration surgery treated with the Osseointegrated Prostheses for the Rehabilitation of Amputees implant system for patients who had trouble utilizing traditional, socket-based prostheses. Of those, 5% (2 of 41) did not undergo surgery, 2% (1 of 41) were lost to follow-up, and 2% (1 of 41) died before the final 2-year follow-up, leaving 90% (37 of 41) for analysis in this prospective, observational trial. Participants were asked to complete the validated Questionnaire for Persons with a Transfemoral Amputation (Q-TFA) and the Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaire before surgery as well as 3, 6, 12, and 24 months after the two-stage procedure. Thirty-seven participants (three women and 34 men; mean ± SD age 38 ± 10 years) reached the 24-month follow-up visit, and four patients were withdrawn. We tabulated the frequency and types of surgical complications that patients experienced and calculated the anchored-based MCID for the Q-TFA global score (0 to 100 maximum). The Q-TFA’s global score is generated based on answers to three questions: “How would you summarize your level of function with your current prosthesis?”, “How would you summarize the problems you experience with your current prosthesis?”, and “How would you summarize your overall situation as an amputee?” Using the sum of the numerical scores for the three questions, we found the difference between the baseline and the final follow-up for the participants. Then, we took the first quartile of the difference to represent the median change in the lower 25% of the data and used this value as our MCID. Results: Scores in the study group improved in nearly all domains of the Q-TFA and PROMIS, including those related to prosthetic use, prosthetic mobility, and physical function (all p < 0.05). Patients developed superficial infections in 29% (15 of 51) of implanted limbs, all of which were treated successfully with antibiotics alone; 7 patients developed deep infections, only 1 of which involved the bone and implant. The anchor-based MCID in the Q-TFA global score was calculated as 17 of 100 for this study population. Conclusion: Functional patient-reported outcomes improved in multiple domains among our patient cohort who underwent osseointegration surgery after transfemoral amputation, demonstrating the promise of this technology for patients with unsatisfactory function using conventional, socket-based prostheses. Infections and other complications were lower than in prior studies of osseointegration following limb loss. The novel MCID that we report can be used to determine whether patients have clinically important improvement in future osseointegration surgery studies comparing results between different implants, surgical techniques, and patient populations. Level of Evidence: Level II, therapeutic study.


  • Do Fellowship-educated Military Orthopaedic Oncologists Who Practice in Military Settings Treat a Sufficient Volume of Patients to Maintain Their Oncologic Expertise?

    by Ashley B. Anderson, Julio A. Rivera, James H. Flint, Jason Souza, Benjamin K. Potter, Jonathan A. Forsberg

    Background: Fellowship-trained orthopaedic oncologists in the US military provide routine clinical care and also must maintain readiness to provide combat casualty care. However, low oncologic procedure volume may hinder the ability of these surgeons to maintain relevant surgical expertise. Other low-volume specialties within the Military Health System (MHS) have established partnerships with neighboring civilian centers to increase procedure volume, but the need for similar partnerships for orthopaedic oncologists has not been examined. The purpose of this study was to characterize the practice patterns of US military fellowship–trained orthopaedic oncologists. Questions/purposes: We asked the following questions: (1) What are the diagnoses treated by US military fellowship–trained orthopaedic oncologists? (2) What are the procedures performed by US military fellowship–trained orthopaedic oncologists? Methods: We queried the Military Data Repository, a centralized repository for healthcare data for all healthcare beneficiaries (active duty, dependents, and retirees) within the Defense Health Agency using the MHS’s Management and Reporting Tool for all international common procedure taxonomy (CPT) codes and ICD-9 and ICD-10 codes associated with National Provider Identifier (NPI) numbers of active duty, military fellowship–trained orthopaedic oncologists. Fellowship-trained orthopaedic oncologists were identified by military specialty leaders. Then, we identified all procedures performed by the orthopaedic oncologist based on NPI numbers for fiscal years 2013 to 2022. We stratified the CPT codes by top orthopaedic procedure categories (such as amputation [performed for oncologic and nononcologic reasons], fracture, arthroplasty, oncologic) based on associated ICD codes. These were then tabulated by the most common diagnoses treated. Results: Thirteen percent (796 of 5996) of the diagnoses were oncologic, of which 45% (357 of 796) were malignant. Forty-four percent (158 of 357) of the malignancies were primary and 56% (199 of 357) were secondary; this translates to an average of 2 patients with primary and 2.5 patients with secondary malignancies treated per surgeon per year. During the study period, nine orthopaedic oncologists performed 5996 orthopaedic procedures, or 74 procedures per surgeon per year. Twenty-one percent (1252 of 5996) of the procedures were oncologic; the remaining procedures included 897 arthroplasties, 502 fracture-related, 275 amputations for a nononcologic indication, 204 infections, 142 arthroscopic, and 2724 other procedures. Conclusion: Although military orthopaedic oncologists possess expert skills that are directly translatable to combat casualty care and operational readiness, within MHS hospitals they treat relatively few patients with oncologic diagnoses, and less than one-half of those involve malignancies. Clinical Relevance: Despite postgraduation procedure volume raining stable over the last decade, it is unknown how many new patient visits for oncologic diagnoses and how many corresponding tumor procedures are necessary to maintain competence or build confidence after musculoskeletal oncology fellowship training. It is important to note that there are no military orthopaedic oncology fellowships, and all active duty orthopaedic oncologists undergo training at civilian institutions. Military-civilian partnerships with high-volume cancer centers may enable military orthopaedic oncologists to work at civilian cancer centers to increase their oncologic volume to ensure sustainment of operationally relevant knowledge, skills, and abilities and improve patient care and outcomes.


  • Open Access

    The Hierarchy of Needs: A Problem-based Framework for Extremity Reconstruction

    by Aurora M. Kareh, Jason M. Souza

    Summary: Plastic and reconstructive surgeons continually evolve their surgical strategies with the aim of achieving the optimal patient outcome. Numerous well-known frameworks intended to guide reconstructive planning have been introduced and are entrenched in plastic surgery education, but are limited in their scope due to their procedure-based construct. Here, we introduce the hierarchy of reconstructive needs: a problem-based reconstructive framework that shifts operative planning to the specific needs of the defect and goals for restoration of normality while allowing for further innovation and evolution beyond our existing surgical capabilities.